BioHiTech Global Inc logo

BHTG - BioHiTech Global Inc Share Price

$1.9 0.0  1.1%

Last Trade - 26/02/21

Sector
Industrials
Size
Micro Cap
Market Cap £31.8m
Enterprise Value £58.3m
Revenue £3.15m
Position in Universe 5585th / 6715
Bullish
Bearish
Unlock BHTG Revenue
Momentum
Relative Strength (%)
1m +10.5%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -56.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
1.52 1.51 2.24 2.42 3.36 4.22 4.39 7.69 +22.7%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2020,BioHiTech Global Inc revenues increased 5% to $3.4M. Netloss applicable to common stockholders increased 46% to$9.1M. Revenues reflect HEBioT (related party) increase of56% to $1.4M, Equipment sales increase from $138K to $617K.Higher net loss reflects Interest expense increase of 34%to $3.1M (expense), Impairment Expense increase from $347Kto $917K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BHTG Revenue Unlock BHTG Revenue

Net Income

BHTG Net Income Unlock BHTG Revenue

Normalised EPS

BHTG Normalised EPS Unlock BHTG Revenue

PE Ratio Range

BHTG PE Ratio Range Unlock BHTG Revenue

Dividend Yield Range

BHTG Dividend Yield Range Unlock BHTG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BHTG EPS Forecasts Unlock BHTG Revenue
Profile Summary

BioHiTech Global, Inc. provides an environmentally friendly solution for food waste disposal. The Company, through its subsidiaries offers its customers various technologies integrating technological, biological and mechanical engineering solutions for the control, reduction and/or reuse of organic waste. The Company has a global distribution license to sell, lease, use, distribute and manufacture the Eco-Safe Digester product. The Eco-Safe Digester is a data-driven, network-based mechanical/biological technology, which transforms food waste into nutrient-neutral water that can be disposed of through conventional sanitary sewer systems. The Eco-Safe Digester is used by businesses in food service, hospitality, healthcare, government, conference centers and education centers or stadiums. The Company’s wholly-owned subsidiaries are BioHiTech America, LLC, BioHiTech Europe Limited, BHT Financial, LLC and E.N.A. Renewables LLC.

Directors
Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated March 20, 2013
Public Since March 27, 2014
No. of Shareholders: 55
No. of Employees: 39
Sector Industrials
Industry Professional & Commercial Services
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 23,354,130
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BHTG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BHTG
Upcoming Events for BHTG
Frequently Asked Questions for BioHiTech Global Inc
What is the BioHiTech Global Inc share price?

As of 26/02/21, shares in BioHiTech Global Inc are trading at $1.9, giving the company a market capitalisation of £31.8m. This share price information is delayed by 15 minutes.

How has the BioHiTech Global Inc share price performed this year?

Shares in BioHiTech Global Inc are currently trading at $1.9 and the price has moved by 8.57% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the BioHiTech Global Inc price has moved by -16.24% over the past year.

What are the analyst and broker recommendations for BioHiTech Global Inc?

Of the analysts with advisory recommendations for BioHiTech Global Inc, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for BioHiTech Global Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will BioHiTech Global Inc next release its financial results?

BioHiTech Global Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the BioHiTech Global Inc dividend yield?

BioHiTech Global Inc does not currently pay a dividend.

Does BioHiTech Global Inc pay a dividend?

BioHiTech Global Inc does not currently pay a dividend.

When does BioHiTech Global Inc next pay dividends?

BioHiTech Global Inc does not currently pay a dividend.

How do I buy BioHiTech Global Inc shares?

To buy shares in BioHiTech Global Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of BioHiTech Global Inc?

Shares in BioHiTech Global Inc are currently trading at $1.9, giving the company a market capitalisation of £31.8m.

Where are BioHiTech Global Inc shares listed? Where are BioHiTech Global Inc shares listed?

Here are the trading details for BioHiTech Global Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: BHTG
What kind of share is BioHiTech Global Inc?

Based on an overall assessment of its quality, value and momentum, BioHiTech Global Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a BioHiTech Global Inc share price forecast 2021?

Shares in BioHiTech Global Inc are currently priced at $1.9. At that level they are trading at 84.21% discount to the analyst consensus target price of 0.00.

Analysts covering BioHiTech Global Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.545 for the next financial year.

How can I tell whether the BioHiTech Global Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioHiTech Global Inc. Over the past six months, the relative strength of its shares against the market has been 32.58%. At the current price of $1.9, shares in BioHiTech Global Inc are trading at 26.21% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the BioHiTech Global Inc PE Ratio?

We were not able to find PE ratio data for BioHiTech Global Inc.

Who are the key directors of BioHiTech Global Inc?

We were unable to find the directors for BioHiTech Global Inc.

Who are the major shareholders of BioHiTech Global Inc?

Here are the top five shareholders of BioHiTech Global Inc based on the size of their shareholding:

Celli (Frank E) Individual Investor
Percentage owned: 10.5% (2.45m shares)
EntsorgaFin SpA Corporation
Percentage owned: 4.44% (1.04m shares)
Conundrum Capital Partners, L.L.C. Corporation
Percentage owned: 3.92% (914k shares)
Joyce (Robert A) Individual Investor
Percentage owned: 1.8% (422k shares)
Essman (Brian C) Individual Investor
Percentage owned: 0.88% (205k shares)
Similar to BHTG
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.